Skip to content

Bn2 Diffuse Large B Cell Lymphoma C4725003

Published: July 22, 2026Updated: August 20, 2026

An aggressive form of non-Hodgkin lymphoma affecting white blood cells. It typically occurs in adults and is treated with chemotherapy regimens, often combined with immunotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C83.37
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Medication Comparisons

Compare medications used to treat Bn2 Diffuse Large B Cell Lymphoma C4725003. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy